Carolina Rudah
- Novo Nordisk (NVO) has laid off dozens of employees at the largest U.S. manufacturing site for its blockbuster obesity and diabetes drugs, a Reuters review of LinkedIn posts showed.
- The previously unreported cuts included staff in manufacturing roles, from quality control
